Canada Glucose Monitoring Device Market, By Product Type (Self Blood Glucose Monitoring Devices, Continuous Glucose Monitoring Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), End User (Home Care Settings, Hospital, Others), By Region and Competition, 2020-2030F

Market Overview

Canada Glucose Monitoring Device Market was valued at USD 1.23 billion in 2024 and is expected to reach USD 2.54 billion by 2030 with a CAGR of 12.85% during the forecast period. The rise in technological advancements are driving the glucose monitoring devices market growth. Moreover, Prevalence of Diabetes indicates a significant public health concern and thereby driving the demand for glucose monitoring devices. According to Health Canada, the prevalence of diabetes is anticipated to significantly increase in the next three decades, with the number of affected individuals more than doubling from approximately 529 million to 1.3 billion by 2050. This silent epidemic, impacting around 6.1 percent of the global population, is identified as a major contributor to mortality and morbidity worldwide by The Lancet. It is estimated that by 2050, one out of every ten individuals globally will be affected by diabetes.

Key Market Drivers

Rising Prevalence of Diabetes in Canada

The increasing incidence of diabetes is a significant driver for the glucose monitoring device market in Canada. As of 2020–2021, approximately 9.4% of Canadians aged one year and older were living with diagnosed diabetes, equating to about 3.7 million individuals. This prevalence escalates with age, reaching 27% among those aged 65 and older. The growing number of diabetes cases necessitates effective monitoring solutions, thereby boosting the demand for glucose monitoring devices.​

The rising prevalence of diabetes underscores the urgent need for effective monitoring solutions. Glucose monitoring devices, such as continuous glucose monitors (CGMs) and flash glucose monitors (FGMs), play a crucial role in enabling individuals to manage their blood sugar levels effectively. These devices provide real-time data, allowing for timely interventions and reducing the risk of complications associated with uncontrolled diabetes, such as cardiovascular diseases, kidney failure, and neuropathy.​

Moreover, the economic burden of diabetes on the healthcare system is substantial. By facilitating better glycemic control, glucose monitoring devices can help reduce hospital admissions and associated healthcare costs. As the prevalence of diabetes continues to rise, the demand for advanced glucose monitoring solutions is expected to grow correspondingly, driving market expansion in Canada.​

Government Initiatives to Enhance Access to Monitoring Devices

The Canadian government has implemented various programs to improve access to diabetes management tools. For instance, Alberta expanded public coverage of continuous glucose monitors (CGMs) to all age groups in December 2024, removing previous age restrictions. This policy change is expected to benefit approximately 23,000 additional Albertans living with type 1 diabetes, enabling them to access life-saving CGM technology.​

Similarly, British Columbia's PharmaCare provides coverage for CGMs and flash glucose monitors (FGMs) through Special Authority. Eligible individuals covered under plans such as Fair PharmaCare, Plan C (Income Assistance), Plan F (At Home Program), and Plan W (First Nations Health Benefits) can receive coverage for these devices, provided they meet specific medical criteria. Initial coverage is granted for one year, with the possibility of renewal for five years upon reassessment.​

These government initiatives aim to alleviate financial barriers and promote the adoption of advanced glucose monitoring technologies. By expanding coverage and making these devices more accessible, the government is supporting individuals in managing their diabetes effectively, ultimately improving health outcomes and reducing the long-term burden on the healthcare system.

Download Free Sample Report

Key Market Challenges

High Cost of Advanced Monitoring Devices

Despite the benefits of advanced glucose monitoring devices, their high cost remains a barrier to widespread adoption. While government programs provide some coverage, not all patients qualify, and out-of-pocket expenses can be substantial. For example, individuals with type 1 diabetes in Alberta may incur up to $7,000 annually in out-of-pocket expenses, while those managing type 2 diabetes may face costs up to $6,000. These financial burdens can deter individuals from utilizing these technologies, potentially impacting their diabetes management.​

The high cost of CGMs and FGMs includes not only the initial purchase price but also ongoing expenses for sensors and transmitters. For individuals without comprehensive insurance coverage or those who do not meet the eligibility criteria for government programs, these costs can be prohibitive.​

Limited Awareness and Education on Device Usage

A lack of awareness and education regarding the proper use of glucose monitoring devices poses a challenge in Canada. Some patients may be unaware of the availability of advanced monitoring options or may not receive adequate training on their use. This gap can lead to suboptimal device utilization and hinder effective diabetes management. Addressing this issue requires concerted efforts from healthcare providers, policymakers, and community organizations to enhance education and support for individuals with diabetes.

Key Market Trends

Adoption of Advanced Glucose Monitoring Technologies

There is a growing trend towards the adoption of advanced glucose monitoring technologies, such as continuous glucose monitoring (CGM) systems. These devices offer real-time glucose readings, enhancing diabetes management and patient outcomes. The shift towards advanced technologies is driven by the benefits they offer over traditional finger-prick methods. CGMs provide continuous data, allowing for better glycemic control and reducing the risk of hypoglycemia and hyperglycemia. They also enhance the quality of life for individuals with diabetes by reducing the need for frequent finger-stick tests and providing insights into glucose trends and patterns.​

Furthermore, the integration of CGMs with insulin pumps and mobile applications enables automated insulin delivery and real-time data sharing with healthcare providers. This integration facilitates personalized treatment plans and timely interventions, contributing to improved health outcomes. As awareness of these benefits grows, the adoption of advanced glucose monitoring technologies is expected to continue rising in Canada.

Integration of Digital Health Solutions

The integration of digital health solutions into glucose monitoring is reshaping diabetes care in Canada. Modern devices now offer features such as smartphone connectivity, cloud-based data storage, and real-time alerts, facilitating better patient engagement and remote monitoring by healthcare providers. This digital transformation aligns with the broader healthcare trend towards personalized and data-driven care, improving disease management and patient adherence.​

Digital health solutions enable individuals to track their glucose levels, physical activity, diet, and medication adherence in one platform. This comprehensive approach empowers patients to take an active role in managing their condition and allows healthcare providers to monitor progress and adjust treatment plans as needed.​

Moreover, the use of artificial intelligence and machine learning algorithms in digital health platforms can provide predictive analytics, identifying patterns and potential complications before they occur. This proactive approach to diabetes management can lead to early interventions, reducing the risk of severe complications and hospitalizations.​

As technology continues to advance, the integration of digital health solutions into glucose monitoring is expected to become increasingly sophisticated, offering more personalized and efficient care for individuals with diabetes in Canada.

Segmental Insights

Application Insights

Based on Application, Type 2 diabetes represents the largest application segment. This prominence is primarily due to the high prevalence of Type 2 diabetes among Canadians, which necessitates regular blood glucose monitoring to manage the condition effectively. The widespread adoption of glucose monitoring devices for Type 2 diabetes management underscores their critical role in controlling blood sugar levels, preventing complications, and improving patient outcomes.​

The increasing incidence of Type 2 diabetes in Canada is influenced by factors such as aging population, sedentary lifestyles, and rising obesity rates. These factors contribute to the growing demand for glucose monitoring devices, as individuals and healthcare providers seek efficient tools to monitor and manage blood glucose levels. The emphasis on early detection and proactive management of Type 2 diabetes further drives the adoption of these devices, solidifying their position as the leading application segment in the market.​

Moreover, advancements in glucose monitoring technology, including the development of user-friendly and accurate devices, have facilitated their integration into routine diabetes care. The convenience and accessibility of modern glucose monitors encourage consistent use among patients, thereby enhancing disease management and quality of life for those living with Type 2 diabetes.

Download Free Sample Report

Regional Insights

Based on the region, ​Ontario holds a prominent position in Canada's glucose monitoring device market, largely due to its substantial population and the high prevalence of diabetes within the province. As of 2023, approximately 991,600 adults in Ontario were diagnosed with diabetes, making it the province with the highest number of cases in the country. This significant diabetic population drives the demand for effective glucose monitoring solutions to manage and control blood sugar levels.​

The Greater Toronto Area (GTA), a major urban center in Ontario, exhibits some of the highest diabetes prevalence rates in the province, with certain areas reporting rates up to 13%. The concentration of healthcare facilities, availability of advanced medical technologies, and increased health awareness in the GTA contribute to the widespread adoption of glucose monitoring devices. These factors collectively position Ontario as a leading market for glucose monitoring devices in Canada, reflecting the province's commitment to addressing the challenges posed by diabetes through effective monitoring and management strategies.

Recent Developments

• In July 2023, Dexcom received authorization for the G7 continuous glucose monitoring (CGM) system in Canada. This system is now available for individuals aged two and older, regardless of the type of diabetes they have.
• In March 2023, Dexcom announced that residents of Manitoba living with either type 1 or type 2 diabetes are eligible for coverage of its G6 CGM system. At the time of the announcement, Manitoba stood out as the only Canadian province that did not require a preapproval application for coverage, simplifying access to the technology for those in need.

Key Market Players

• Medtronic of Canada Ltd
• Abbott Canada.
• Johnson & Johnson Inc/Canada
• Braun of Canada
• F. Hoffmann-La Roche Limited.
• Ascensia Diabetes Care.
• Sanofi-Aventis Canada Inc.
• Eli Lilly Canada Inc.

Report Scope:

In this report, the Canada glucose monitoring device market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Canada Glucose Monitoring Device Market, By Product Type:

o   Self-Blood Glucose Monitoring Devices

o   Continuous Glucose Monitoring Devices

·         Canada Glucose Monitoring Device Market, By Application:

o   Type 1 Diabetes

o   Type 2 Diabetes

o   Gestational Diabetes

·         Canada Glucose Monitoring Device Market, By End User:

o   Home Care Settings

o   Hospital

o   Others

·         Canada Glucose Monitoring Device Market, By Region:

o   Ontario

o   Quebec

o   Alberta

o   British Columbia

o   Saskatchewan and Manitoba

o   Rest of Canada

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Canada Glucose Monitoring Device Market.

Available Customizations:

Canada Glucose Monitoring Device Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

The Canada glucose monitoring device market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com